Clinical Trials for Head & Neck Cancer
RTOG-1216
Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck Cancer. View Details.
Medical Oncology: 706.353.2990
Radiation Oncology: 706.548.0500
Surgical Oncology: 706.715.2430
Breast Health Program: 762.356.4780
Pharmacy: 706.353.4344
Referrals: 706.353.4346
Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck Cancer. View Details.